Genetic Testing - Global Market Outlook (2017-2026)
According to Stratistics MRC, the Global Genetic Testing market is accounted for $7749.00 million in 2017 and is expected to reach $25948.46 million by 2026 growing at a CAGR of 14.37% during the forecast period. Factors such as rise in the incidence of genetic diseases and increase in the prevalence of cancer and cardiovascular diseases are fuelling the market growth. Moreover, demand in the benefits offered by genetic testing (such as specificity and early identification) is one of the major opportunities to boost the market during the forecast period. However, inaccuracies in results and reimbursement issues are restricting the growth of the market.
A genetic test is used to determine the DNA sequence of a certain region of the human genome. This region might be a whole gene or a share of a gene, or other areas thought to regulate genes. The test will look for certain changes in the sequence that is known to have consequences on the function of a gene. Mostly genetic tests are performed on a DNA sample, because every tissue in the body is composed of cells that contain DNA.
By type, predictive & pre-symptomatic testing segment acquired significant growth due to increase in awareness about diseases such as cancer and early detection of diseases. Based on end user, hospital based laboratories segment is owing to user convenience and increasing number of hospitals are a few factors projected to propel the hospital-based laboratories segment during the forecast period.
On the basis of geography, North America is considered as the fastest growing market and the factors favouring the growth of this region are developed infrastructure, increase in health care investments, and robust R&D activities in these countries.
Some of the key players in genetic testing market include Illumina Inc, Abbott Laboratories, BGI Tech, Thermo Fisher Sceintific, Luminex Corporation, Cepheid, Qiagen N.V, Blueprint Genetic, Pacific Biosciences of California Inc, Affymetrix, Bio-Rad Laboratories, Celera Group, AutoGenomics Inc., Roche Diagnostics Limited, Molecular Inc., Genomictre Inc, HTG Molecular Diagnostics Inc, Oxford Biodynamics Ltd, Roche Holding AG and National Center for Biotechnology Information.
Technologies Covered:
A genetic test is used to determine the DNA sequence of a certain region of the human genome. This region might be a whole gene or a share of a gene, or other areas thought to regulate genes. The test will look for certain changes in the sequence that is known to have consequences on the function of a gene. Mostly genetic tests are performed on a DNA sample, because every tissue in the body is composed of cells that contain DNA.
By type, predictive & pre-symptomatic testing segment acquired significant growth due to increase in awareness about diseases such as cancer and early detection of diseases. Based on end user, hospital based laboratories segment is owing to user convenience and increasing number of hospitals are a few factors projected to propel the hospital-based laboratories segment during the forecast period.
On the basis of geography, North America is considered as the fastest growing market and the factors favouring the growth of this region are developed infrastructure, increase in health care investments, and robust R&D activities in these countries.
Some of the key players in genetic testing market include Illumina Inc, Abbott Laboratories, BGI Tech, Thermo Fisher Sceintific, Luminex Corporation, Cepheid, Qiagen N.V, Blueprint Genetic, Pacific Biosciences of California Inc, Affymetrix, Bio-Rad Laboratories, Celera Group, AutoGenomics Inc., Roche Diagnostics Limited, Molecular Inc., Genomictre Inc, HTG Molecular Diagnostics Inc, Oxford Biodynamics Ltd, Roche Holding AG and National Center for Biotechnology Information.
Technologies Covered:
- Biochemical Testing
- Cytogenetic testing
- Alzheimer Disease
- Cystic Fibrosis
- Huntington Disease
- Duchenne Muscular Dystrophy
- Sickle Cell Anemia
- Cancer Disease
- Thalassemia
- Special Diseases
- Other Diseases
- Predictive & Pre-symptomatic Testing
- Carrier Testing
- Nutrigenomic Testing
- Forensic Testing
- Newborn and Prenatal Testing
- Molecular Genetic Test/ DNA Test
- Tandem Mass Spectrometry
- High-performance liquid chromatography
- Gas Chromatography/ Mass Spectrometry
- Other Types
- Saliva
- Hair
- Blood
- Tumors
- Other Testing Samples
- Cancer Genetic Testing
- Prescribed Genetic Testing
- Pharmacogenomics Genetic Testing
- Predisposition Cancer Genetic Testing
- Direct to consumer (DTC) Genetic Testing
- Neurogenetic Disorder Testing
- Muscular Dystrophies
- Other Applications
- Blood Bank
- Hospitals
- Nursing Homes
- Laboratories
- Specialty clinics
- Other End Users
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements.
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Biochemical Testing
5.3 Cytogenetic testing
6 GLOBAL GENETIC TESTING MARKET, BY DISEASE
6.1 Introduction
6.2 Alzheimer Disease
6.3 Cystic Fibrosis
6.4 Huntington Disease
6.5 Duchenne Muscular Dystrophy
6.6 Sickle Cell Anemia
6.7 Cancer Disease
6.8 Thalassemia
6.9 Special Diseases
6.10 Other Diseases
7 GLOBAL GENETIC TESTING MARKET, BY TYPE
7.1 Introduction
7.2 Predictive & Pre-symptomatic Testing
7.3 Carrier Testing
7.4 Nutrigenomic Testing
7.5 Forensic Testing
7.6 Newborn and Prenatal Testing
7.6.1 Preimplantation Genetic Diagnosis
7.6.2 Diagnostic Techniques
7.6.2.1 Fluorescence in situ hybridization (FISH)
7.6.2.2 Polymerase chain reaction (PCR)
7.6.2.3 Comparative genomic hybridization (CGH)
7.6.3 Screening Methods
7.6.3.1 Maternal serum screening (MSS)
7.6.3.2 Noninvasive prenatal testing (NIPT)
7.7 Molecular Genetic Test/ DNA Test
7.7.1 Direct Sequencing
7.7.2 DNA Microarray Analysis
7.7.3 Chromosomal Genetic Test
7.7.4 Other Molecular Genetic Test/ DNA Tests
7.8 Tandem Mass Spectrometry
7.9 High-performance liquid chromatography
7.10 Gas Chromatography/ Mass Spectrometry
7.11 Other Types
8 GLOBAL GENETIC TESTING MARKET, BY TESTING SAMPLE
8.1 Introduction
8.2 Saliva
8.3 Hair
8.4 Blood
8.5 Tumors
8.6 Other Testing Samples
9 GLOBAL GENETIC TESTING MARKET, BY APPLICATION
9.1 Introduction
9.2 Cancer Genetic Testing
9.3 Prescribed Genetic Testing
9.4 Pharmacogenomics Genetic Testing
9.5 Predisposition Cancer Genetic Testing
9.6 Direct to consumer (DTC) Genetic Testing
9.7 Neurogenetic Disorder Testing
9.8 Muscular Dystrophies
9.9 Other Applications
10 GLOBAL GENETIC TESTING MARKET, BY END USER
10.1 Introduction
10.2 Blood Bank
10.3 Hospitals
10.4 Nursing Homes
10.5 Laboratories
10.6 Specialty clinics
10.7 Other End Users
11 GLOBAL GENETIC TESTING MARKET, BY GEOGRAPHY
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 KEY DEVELOPMENTS
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 COMPANY PROFILING
13.1 Illumina Inc
13.2 Abbott Laboratories
13.3 BGI Tech
13.4 Thermo Fisher Sceintific
13.5 Luminex Corporation
13.6 Cepheid
13.7 Qiagen N.V
13.8 Blueprint Genetic
13.9 Pacific Biosciences of California Inc
13.10 Affymetrix
13.11 Bio-Rad Laboratories
13.12 Celera Group
13.13 AutoGenomics Inc.
13.14 Roche Diagnostics Limited
13.15 Molecular Inc.
13.16 Genomictre Inc
13.17 HTG Molecular Diagnostics Inc
13.18 Oxford Biodynamics Ltd
13.19 Roche Holding AG
13.20 National Center for Biotechnology Information
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Biochemical Testing
5.3 Cytogenetic testing
6 GLOBAL GENETIC TESTING MARKET, BY DISEASE
6.1 Introduction
6.2 Alzheimer Disease
6.3 Cystic Fibrosis
6.4 Huntington Disease
6.5 Duchenne Muscular Dystrophy
6.6 Sickle Cell Anemia
6.7 Cancer Disease
6.8 Thalassemia
6.9 Special Diseases
6.10 Other Diseases
7 GLOBAL GENETIC TESTING MARKET, BY TYPE
7.1 Introduction
7.2 Predictive & Pre-symptomatic Testing
7.3 Carrier Testing
7.4 Nutrigenomic Testing
7.5 Forensic Testing
7.6 Newborn and Prenatal Testing
7.6.1 Preimplantation Genetic Diagnosis
7.6.2 Diagnostic Techniques
7.6.2.1 Fluorescence in situ hybridization (FISH)
7.6.2.2 Polymerase chain reaction (PCR)
7.6.2.3 Comparative genomic hybridization (CGH)
7.6.3 Screening Methods
7.6.3.1 Maternal serum screening (MSS)
7.6.3.2 Noninvasive prenatal testing (NIPT)
7.7 Molecular Genetic Test/ DNA Test
7.7.1 Direct Sequencing
7.7.2 DNA Microarray Analysis
7.7.3 Chromosomal Genetic Test
7.7.4 Other Molecular Genetic Test/ DNA Tests
7.8 Tandem Mass Spectrometry
7.9 High-performance liquid chromatography
7.10 Gas Chromatography/ Mass Spectrometry
7.11 Other Types
8 GLOBAL GENETIC TESTING MARKET, BY TESTING SAMPLE
8.1 Introduction
8.2 Saliva
8.3 Hair
8.4 Blood
8.5 Tumors
8.6 Other Testing Samples
9 GLOBAL GENETIC TESTING MARKET, BY APPLICATION
9.1 Introduction
9.2 Cancer Genetic Testing
9.3 Prescribed Genetic Testing
9.4 Pharmacogenomics Genetic Testing
9.5 Predisposition Cancer Genetic Testing
9.6 Direct to consumer (DTC) Genetic Testing
9.7 Neurogenetic Disorder Testing
9.8 Muscular Dystrophies
9.9 Other Applications
10 GLOBAL GENETIC TESTING MARKET, BY END USER
10.1 Introduction
10.2 Blood Bank
10.3 Hospitals
10.4 Nursing Homes
10.5 Laboratories
10.6 Specialty clinics
10.7 Other End Users
11 GLOBAL GENETIC TESTING MARKET, BY GEOGRAPHY
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 KEY DEVELOPMENTS
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 COMPANY PROFILING
13.1 Illumina Inc
13.2 Abbott Laboratories
13.3 BGI Tech
13.4 Thermo Fisher Sceintific
13.5 Luminex Corporation
13.6 Cepheid
13.7 Qiagen N.V
13.8 Blueprint Genetic
13.9 Pacific Biosciences of California Inc
13.10 Affymetrix
13.11 Bio-Rad Laboratories
13.12 Celera Group
13.13 AutoGenomics Inc.
13.14 Roche Diagnostics Limited
13.15 Molecular Inc.
13.16 Genomictre Inc
13.17 HTG Molecular Diagnostics Inc
13.18 Oxford Biodynamics Ltd
13.19 Roche Holding AG
13.20 National Center for Biotechnology Information
LIST OF TABLES
Table 1 Global Genetic Testing Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Genetic Testing Market Outlook, By Technology (2016-2026) ($MN)
Table 3 Global Genetic Testing Market Outlook, By Biochemical Testing (2016-2026) ($MN)
Table 4 Global Genetic Testing Market Outlook, By Cytogenetic testing (2016-2026) ($MN)
Table 5 Global Genetic Testing Market Outlook, By Disease (2016-2026) ($MN)
Table 6 Global Genetic Testing Market Outlook, By Alzheimer Disease (2016-2026) ($MN)
Table 7 Global Genetic Testing Market Outlook, By Cystic Fibrosis (2016-2026) ($MN)
Table 8 Global Genetic Testing Market Outlook, By Huntington Disease (2016-2026) ($MN)
Table 9 Global Genetic Testing Market Outlook, By Duchenne Muscular Dystrophy (2016-2026) ($MN)
Table 10 Global Genetic Testing Market Outlook, By Sickle Cell Anemia (2016-2026) ($MN)
Table 11 Global Genetic Testing Market Outlook, By Cancer Disease (2016-2026) ($MN)
Table 12 Global Genetic Testing Market Outlook, By Thalassemia (2016-2026) ($MN)
Table 13 Global Genetic Testing Market Outlook, By Special Diseases (2016-2026) ($MN)
Table 14 Global Genetic Testing Market Outlook, By Other Diseases (2016-2026) ($MN)
Table 15 Global Genetic Testing Market Outlook, By Type (2016-2026) ($MN)
Table 16 Global Genetic Testing Market Outlook, By Predictive & Pre-symptomatic Testing (2016-2026) ($MN)
Table 17 Global Genetic Testing Market Outlook, By Carrier Testing (2016-2026) ($MN)
Table 18 Global Genetic Testing Market Outlook, By Nutrigenomic Testing (2016-2026) ($MN)
Table 19 Global Genetic Testing Market Outlook, By Forensic Testing (2016-2026) ($MN)
Table 20 Global Genetic Testing Market Outlook, By Newborn and Prenatal Testing (2016-2026) ($MN)
Table 21 Global Genetic Testing Market Outlook, By Preimplantation Genetic Diagnosis (2016-2026) ($MN)
Table 22 Global Genetic Testing Market Outlook, By Diagnostic Techniques (2016-2026) ($MN)
Table 23 Global Genetic Testing Market Outlook, By Screening Methods (2016-2026) ($MN)
Table 24 Global Genetic Testing Market Outlook, By Molecular Genetic Test/ DNA Test (2016-2026) ($MN)
Table 25 Global Genetic Testing Market Outlook, By Direct Sequencing (2016-2026) ($MN)
Table 26 Global Genetic Testing Market Outlook, By DNA Microarray Analysis (2016-2026) ($MN)
Table 27 Global Genetic Testing Market Outlook, By Chromosomal Genetic Test (2016-2026) ($MN)
Table 28 Global Genetic Testing Market Outlook, By Other Molecular Genetic Test/ DNA Tests (2016-2026) ($MN)
Table 29 Global Genetic Testing Market Outlook, By Tandem Mass Spectrometry (2016-2026) ($MN)
Table 30 Global Genetic Testing Market Outlook, By High-performance liquid chromatography (2016-2026) ($MN)
Table 31 Global Genetic Testing Market Outlook, By Gas Chromatography/ Mass Spectrometry (2016-2026) ($MN)
Table 32 Global Genetic Testing Market Outlook, By Other Types (2016-2026) ($MN)
Table 33 Global Genetic Testing Market Outlook, By Testing Sample (2016-2026) ($MN)
Table 34 Global Genetic Testing Market Outlook, By Saliva (2016-2026) ($MN)
Table 35 Global Genetic Testing Market Outlook, By Hair (2016-2026) ($MN)
Table 36 Global Genetic Testing Market Outlook, By Blood (2016-2026) ($MN)
Table 37 Global Genetic Testing Market Outlook, By Tumors (2016-2026) ($MN)
Table 38 Global Genetic Testing Market Outlook, By Other Testing Samples (2016-2026) ($MN)
Table 39 Global Genetic Testing Market Outlook, By Application (2016-2026) ($MN)
Table 40 Global Genetic Testing Market Outlook, By Cancer Genetic Testing (2016-2026) ($MN)
Table 41 Global Genetic Testing Market Outlook, By Prescribed Genetic Testing (2016-2026) ($MN)
Table 42 Global Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing (2016-2026) ($MN)
Table 43 Global Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing (2016-2026) ($MN)
Table 44 Global Genetic Testing Market Outlook, By Direct to consumer (DTC) Genetic Testing (2016-2026) ($MN)
Table 45 Global Genetic Testing Market Outlook, By Neurogenetic Disorder Testing (2016-2026) ($MN)
Table 46 Global Genetic Testing Market Outlook, By Muscular Dystrophies (2016-2026) ($MN)
Table 47 Global Genetic Testing Market Outlook, By Other Applications (2016-2026) ($MN)
Table 48 Global Genetic Testing Market Outlook, By End User (2016-2026) ($MN)
Table 49 Global Genetic Testing Market Outlook, By Blood Bank (2016-2026) ($MN)
Table 50 Global Genetic Testing Market Outlook, By Hospitals (2016-2026) ($MN)
Table 51 Global Genetic Testing Market Outlook, By Nursing Homes (2016-2026) ($MN)
Table 52 Global Genetic Testing Market Outlook, By Laboratories (2016-2026) ($MN)
Table 53 Global Genetic Testing Market Outlook, By Specialty clinics (2016-2026) ($MN)
Table 54 Global Genetic Testing Market Outlook, By Other End Users (2016-2026) ($MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America, Middle East & Africa are represented in the same manner above.
Table 1 Global Genetic Testing Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Genetic Testing Market Outlook, By Technology (2016-2026) ($MN)
Table 3 Global Genetic Testing Market Outlook, By Biochemical Testing (2016-2026) ($MN)
Table 4 Global Genetic Testing Market Outlook, By Cytogenetic testing (2016-2026) ($MN)
Table 5 Global Genetic Testing Market Outlook, By Disease (2016-2026) ($MN)
Table 6 Global Genetic Testing Market Outlook, By Alzheimer Disease (2016-2026) ($MN)
Table 7 Global Genetic Testing Market Outlook, By Cystic Fibrosis (2016-2026) ($MN)
Table 8 Global Genetic Testing Market Outlook, By Huntington Disease (2016-2026) ($MN)
Table 9 Global Genetic Testing Market Outlook, By Duchenne Muscular Dystrophy (2016-2026) ($MN)
Table 10 Global Genetic Testing Market Outlook, By Sickle Cell Anemia (2016-2026) ($MN)
Table 11 Global Genetic Testing Market Outlook, By Cancer Disease (2016-2026) ($MN)
Table 12 Global Genetic Testing Market Outlook, By Thalassemia (2016-2026) ($MN)
Table 13 Global Genetic Testing Market Outlook, By Special Diseases (2016-2026) ($MN)
Table 14 Global Genetic Testing Market Outlook, By Other Diseases (2016-2026) ($MN)
Table 15 Global Genetic Testing Market Outlook, By Type (2016-2026) ($MN)
Table 16 Global Genetic Testing Market Outlook, By Predictive & Pre-symptomatic Testing (2016-2026) ($MN)
Table 17 Global Genetic Testing Market Outlook, By Carrier Testing (2016-2026) ($MN)
Table 18 Global Genetic Testing Market Outlook, By Nutrigenomic Testing (2016-2026) ($MN)
Table 19 Global Genetic Testing Market Outlook, By Forensic Testing (2016-2026) ($MN)
Table 20 Global Genetic Testing Market Outlook, By Newborn and Prenatal Testing (2016-2026) ($MN)
Table 21 Global Genetic Testing Market Outlook, By Preimplantation Genetic Diagnosis (2016-2026) ($MN)
Table 22 Global Genetic Testing Market Outlook, By Diagnostic Techniques (2016-2026) ($MN)
Table 23 Global Genetic Testing Market Outlook, By Screening Methods (2016-2026) ($MN)
Table 24 Global Genetic Testing Market Outlook, By Molecular Genetic Test/ DNA Test (2016-2026) ($MN)
Table 25 Global Genetic Testing Market Outlook, By Direct Sequencing (2016-2026) ($MN)
Table 26 Global Genetic Testing Market Outlook, By DNA Microarray Analysis (2016-2026) ($MN)
Table 27 Global Genetic Testing Market Outlook, By Chromosomal Genetic Test (2016-2026) ($MN)
Table 28 Global Genetic Testing Market Outlook, By Other Molecular Genetic Test/ DNA Tests (2016-2026) ($MN)
Table 29 Global Genetic Testing Market Outlook, By Tandem Mass Spectrometry (2016-2026) ($MN)
Table 30 Global Genetic Testing Market Outlook, By High-performance liquid chromatography (2016-2026) ($MN)
Table 31 Global Genetic Testing Market Outlook, By Gas Chromatography/ Mass Spectrometry (2016-2026) ($MN)
Table 32 Global Genetic Testing Market Outlook, By Other Types (2016-2026) ($MN)
Table 33 Global Genetic Testing Market Outlook, By Testing Sample (2016-2026) ($MN)
Table 34 Global Genetic Testing Market Outlook, By Saliva (2016-2026) ($MN)
Table 35 Global Genetic Testing Market Outlook, By Hair (2016-2026) ($MN)
Table 36 Global Genetic Testing Market Outlook, By Blood (2016-2026) ($MN)
Table 37 Global Genetic Testing Market Outlook, By Tumors (2016-2026) ($MN)
Table 38 Global Genetic Testing Market Outlook, By Other Testing Samples (2016-2026) ($MN)
Table 39 Global Genetic Testing Market Outlook, By Application (2016-2026) ($MN)
Table 40 Global Genetic Testing Market Outlook, By Cancer Genetic Testing (2016-2026) ($MN)
Table 41 Global Genetic Testing Market Outlook, By Prescribed Genetic Testing (2016-2026) ($MN)
Table 42 Global Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing (2016-2026) ($MN)
Table 43 Global Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing (2016-2026) ($MN)
Table 44 Global Genetic Testing Market Outlook, By Direct to consumer (DTC) Genetic Testing (2016-2026) ($MN)
Table 45 Global Genetic Testing Market Outlook, By Neurogenetic Disorder Testing (2016-2026) ($MN)
Table 46 Global Genetic Testing Market Outlook, By Muscular Dystrophies (2016-2026) ($MN)
Table 47 Global Genetic Testing Market Outlook, By Other Applications (2016-2026) ($MN)
Table 48 Global Genetic Testing Market Outlook, By End User (2016-2026) ($MN)
Table 49 Global Genetic Testing Market Outlook, By Blood Bank (2016-2026) ($MN)
Table 50 Global Genetic Testing Market Outlook, By Hospitals (2016-2026) ($MN)
Table 51 Global Genetic Testing Market Outlook, By Nursing Homes (2016-2026) ($MN)
Table 52 Global Genetic Testing Market Outlook, By Laboratories (2016-2026) ($MN)
Table 53 Global Genetic Testing Market Outlook, By Specialty clinics (2016-2026) ($MN)
Table 54 Global Genetic Testing Market Outlook, By Other End Users (2016-2026) ($MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America, Middle East & Africa are represented in the same manner above.
